FBN2 and chronic kidney disease: In the laboratory tests, the median serum cCa, P, and plasma iPTH levels were 9.1 mg/dL, 5.4 mg/dL, and 199.1 pg/mL, respectively, all of which were in the recommended ranges based on the Japanese CKD-MBD guideline [12].